CNTB (Connect Biopharma Holdings Limited) Short-Term Debt to Capital
Connect Biopharma wields significant market influence through the development of rademikibart, an innovative antibody for treating skin inflammation. Business growth is driven by the high efficacy of the therapy in treating colitis and asthma. This price chart reflects a metric of 0.01. The company is currently focusing on strict cost control and the completion of trials, planning to attract a major partner to bring its drugs to market.
Analytical breakdowns for Connect Biopharma
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Connect Biopharma|CNTB - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Connect Biopharma|CNTB - Aggregate Debt Obligations|Debts to Book Capitalization Connect Biopharma Holdings|CNTB - Long-Term Debt Volume|Company Short-Term Debt Connect Biopharma|Quick Liquidity connectbiopharm.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Connect Biopharma Holdings Limited
This indicator measures the share of short-term liabilities within the equity structure, allowing for an assessment of financial stability and the business's sensitivity to interest rate fluctuations. By analyzing the history of short-term debt relative to equity, an investor can determine the extent to which the development of the Connect Biopharma (CNTB) immune modulation ecosystem relies on external loans, which is critical when implementing new therapy standards.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Septerna Pharma (SEPN) - Short-Term Debt to Equity Ratio|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Capital Ratio ANAB (AnaptysBio Inc)|Short-Term Debt to Equity Astria Pharma (ATXS)|enGene Corp - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Current Liabilities to Capital|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|Kyverna Therapeutics Inc. (KYTX) - Short-Term Debt to Equity Ratio|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|CABA: Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio VTYX|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AVTX|Short-Term Debt to Equity ELDN (Eledon Pharmaceuticals Inc.)|Short-Term Debt to Capital AGEN (Agenus Inc)|Short-Term Debt to Capital Coefficient Climb Bio, Inc (CLYM)|ZURA - Short-Term Debt to Equity|Current Liabilities to Capital atyrpharma.com|adagene.com (ADAG) - Short-Term Debt to Equity|Current Liabilities to Equity IMA (Ikena Oncology)|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|EQ: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital IMUX|Short-Term Debt to Capital atarabio.com (ATRA)|Short-Term Debt to Equity InflaRx IFRX|Ratio of Short-Term Indebtedness to Capital XFOR|ACET - Short-Term Debt to Equity|Celularity Inc. (CELU) - Short-Term Debt to Equity Ratio|INMB: Short-Term Debt to Capital|barinthusbio.com (BRNS) - Short-Term Debt to Capital|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc. (SABS)|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|enlivex.com - Short-Term Debt to Capital Ratio|Q32 Bio - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GOVX (geovax.com)|Edesa Biotech - Short-Term Debt to Capital|IBIO: Short-Term Debt to Equity|carismatx.com (CARM) - Short-Term Debt to Equity|Current Liabilities to Equity XTLB (XTL Bio)|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Equity Aditxt, Inc. ADTX|Ratio of Short-Term Indebtedness to Capital GRI|XRTX - Short-Term Debt to Equity|reshapelifesciences.com (HIND) - Short-Term Debt to Equity Ratio|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SCNI|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital Coefficient allakos.com|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS - Short-Term Debt to Equity Ratio|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TCBP (TC Biopharm) - Short-Term Debt to Equity Ratio|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital